Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : ValuEngine, Inc.
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ZS Pharma inc announces closing of initial public offering and full exercise of underwriters' over-allotment option

Monday, 23 Jun 2014 03:56pm EDT 

ZS Pharma Inc:Closes its initial public offering of 6,836,111 shares of common stock at a public offering price of $18.00 per share.This includes the exercise in full by the underwriters of their option to purchase up to 891,667 additional shares of common stock.Net proceeds from the sale of shares, after deducting underwriting discounts, commissions and other estimated offering expenses, will be about $112 million.J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC acted as joint book-running managers for the offering. BMO Capital Markets Corp. acted as lead manager and William Blair & Company, L.L.C. acted as co-manager. 

Company Quote

31 Aug 2015